logo
Plus   Neg
Share
Email

Alexion Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates

Below are the earnings highlights for Alexion Pharmaceuticals Inc. (ALXN):

-Earnings: -$45.0 million in Q4 vs. $30.0 million in the same period last year.
-EPS: -$0.20 in Q4 vs. $0.13 in the same period last year.
-Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $486.4 million or $2.14 per share for the period.
-Analysts projected $1.82 per share
-Revenue: $1.13 billion in Q4 vs. $0.91 billion in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT